Author (number of patient) | Age | Gender | Operation method | pStage | Adjuvant chemotherapy | Time until lung recurrence (months) | Number of lung recurrence | OS from lung resection (months) | Histology |
---|---|---|---|---|---|---|---|---|---|
Miyasaka et al. (1) | 70 | Female (1) | PD (1) | IA (1) | GEM/TS-1 | 16 | 1 (1) | 34 | Well differentiated |
Kurahara et al. (7) | NA | Men (4), female (3) | NA | NA | NA | NA | 1 (7) | 37 | NA |
Ilmer et al. (11) | 66 (49–75) | Men (6), female (5) | PD (10), DP (1) | NA | NA | 17 (3–64) | 1 (11) | 26 | NA |
Tagawa et al. (4) | 69.5 (63–82) | Men (2), female (2) | PD (2), DP (2) | IIA (3), IIB (1) | GEM (4) | 29 (21–47) | 1 (4) | 38 (10–65) | NA |
Okui et al. (6) | 64.5 (63–74) | Men (3), female (3) | PD (3), DP (3) | IB (1), IIA (2), III (1), NA (1) | GEM (4), TS-1 (2) | 26 (0–64) | 1 (5), 2 (1) | 37 (36–48) | Well differentiated (5), mucinous (1) |
Kitasato et al. (1) | 59 | Female (1) | DP (1) | III (1) | 5FU + CDDP | 163 | 1 (1) | 24 ≤ | Well differentiated |